- Home
- HMY vs ELAN Comparison
HMY vs ELAN Comparison
Compare HMY & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- ELAN
- Stock Information
- Founded
- HMY 1950
- ELAN 1954
- Country
- HMY South Africa
- ELAN United States
- Employees
- HMY N/A
- ELAN N/A
- Industry
- HMY Precious Metals
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- HMY Basic Materials
- ELAN Health Care
- Exchange
- HMY Nasdaq
- ELAN Nasdaq
- Market Cap
- HMY 7.7B
- ELAN 5.4B
- IPO Year
- HMY N/A
- ELAN 2018
- Fundamental
- Price
- HMY $12.20
- ELAN $10.32
- Analyst Decision
- HMY Sell
- ELAN Buy
- Analyst Count
- HMY 3
- ELAN 6
- Target Price
- HMY $6.60
- ELAN $15.00
- AVG Volume (30 Days)
- HMY 6.7M
- ELAN 4.9M
- Earning Date
- HMY 01-01-0001
- ELAN 05-07-2025
- Dividend Yield
- HMY 1.24%
- ELAN N/A
- EPS Growth
- HMY 16.30
- ELAN N/A
- EPS
- HMY 0.88
- ELAN 0.68
- Revenue
- HMY $3,553,951,394.00
- ELAN $4,439,000,000.00
- Revenue This Year
- HMY $17.62
- ELAN $3.20
- Revenue Next Year
- HMY $7.93
- ELAN $4.26
- P/E Ratio
- HMY $13.65
- ELAN $15.11
- Revenue Growth
- HMY 16.84
- ELAN 0.50
- 52 Week Low
- HMY $7.21
- ELAN $10.03
- 52 Week High
- HMY $12.49
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- HMY 62.42
- ELAN 38.21
- Support Level
- HMY $11.67
- ELAN $10.03
- Resistance Level
- HMY $12.15
- ELAN $11.19
- Average True Range (ATR)
- HMY 0.46
- ELAN 0.44
- MACD
- HMY 0.12
- ELAN -0.05
- Stochastic Oscillator
- HMY 91.94
- ELAN 20.14
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.